Abstract
There is some debate regarding the safety of methimazole (MMI) therapy during pregnancy. It is not known whether MMI therapy in mothers during pregnancy is safe for their children or if it causes alterations in thyroid function and intellectual development during childhood. Twenty-three children, whose mothers were hyperthyroid during pregnancy and treated with MMI 5–20 mg were studied from age 3–11 yr. Thyroid function and liver function tests, urinary iodine, anti-thyroid antibodies, intelligence quotient (IQ), verbal and functional components of Wechsler test were performed on 23 children of thyrotoxic mothers and 30 controls. In all children T3, T4, RT3U and TSH concentrations were normal. Mean T3, T4 and TSH values were 147 ng/dl, 9.7 µg/dl and 1.2 mU/l, respectively. Height, weight, thyroid function, and thyroid antibodies did not differ from controls. None of the children had T4 below 6 µg/dl or TSH>3.0 mU/l. Liver enzymes and serum albumin were normal in both groups. Mann-Whitney test showed no difference in verbal and performance IQ and their components between children of thyrotoxic mothers and controls. Total IQ of cases and controls was 117±11 and 113±14, respectively. No deleterious effect occurred in thyroid function and physical and intellectual development of children whose mothers were treated during pregnancy with doses of MMI up to 20 mg daily.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beck’s G.P., Burrow G.N. Thyroid disease and pregnancy. Med. Clin. North. Am. 1991, 75: 121–150.
Wing D.A., Millar L.K., Koonings P.P., Montoro M.N., Mestman J.H. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 1994, 170: 90–95.
Dussault J.H. Neonatal screening for congenital hypothyroidism. Clin. Lab. Med. 1993, 13: 645–652.
Marchant B., Brownlie B.E.W., Hart D.M., Horton P.W., Alexander W.D. The placental transfer of propylthiouracil, methimazole and carbimazole. J. Clin. Endocrinol. Metab. 1997, 45: 1187–1193.
Mortimer R.H., Cannel G.R., Addison R.S., et al. MMI and PTU equally cross the perfused human term placental lobule. J. Clin. Endocrinol. Metab. 1991, 82: 3099–3102.
Momotani N., Yoshimura J., Ishikawa N., Ito K. Effect of PTU and MMI on fetal thyroid status in mothers with Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 1997, 82: 3633–3636.
Eisenstein Z., Weiss M., Katz Y., Bank H. Intellectual capacity of subjects exposed to MMI or PTU in utero. Eur. J. Pediatr. 1992, 151: 558–559.
Messer P.M., Hauffa B.P., Olbricht T., Benker G., Korulla P., Reinwein D. Antithyroid drug treatment of Graves’ disease in pregnancy. Acta. Endocrinol. (Copenh). 1990, 123: 311–316.
Wechsler D. Manual for Wechsler preschool and primary scale of intelligence (WPPSI). Psychological Corporation, New York, 1997.
Shahim S. Wechsler intelligence scale for children-revised. Adaptation and standardization. Shiraz University Press, Shiraz, Iran 1994, P. 223.
Hollingshead A.B. Two factor index of social position. Yale University, New Haven, 1965.
Sandell E.B., Kolthoff I.M. Microdetermination of iodine by a catalytic method. Microchem. Acta. 1937, 1: 9–25.
Legrand J. Effects of thyroid hormones on central nervous system development. In: Yanat J. (Ed.), Neurobehavioural Teratology. Elsevier, Amsterdam, 1984, P. 331.
Rozanov C.B., Dratman M.B. Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic system. Neuroscience 1996, 74: 897–915.
Haddow J.E., Palomäki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 1999, 341: 549–555.
Rovet J.F. Congenital hypothyroidism: Long-term outcome. Thyroid 1999, 9: 741–748.
Calaciura F., Mendorla F., Distefano M., et al. Childhood IQ measurement in infants with transient hypothyroidism. Clin. Endocrinol. 1995, 43: 473–477.
Azizi F., Afkhami M., Sarshar A., Nafarabadi M., et al. Childhood IQ measurement in infants on intellectual quotient and psychomotor performance. Int. J. Vitam. Nut. Res. Suppl. 2001, 71: 70–73.
Mandel S.J., Brent G.A., Larsen P.R. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994, 4: 129–133.
Kampmann J.P., Hansen J.E.M. Serum protein binding of propylthiouracil. Br. J. Clin. Pharmacol. 1983, 16: 549–552.
Cooper D.S., Bode H.H., Nath B., Saxe V., Maloof F., Ridway E.C. Methimazole pharmacology in man. J. Clin. Endocrinol. Metab. 1984, 58: 473–479.
Azizi F., Kalani H., Kimiagar M., et al. Physical, neuromotor and intellectual impairment in non-cretinous schoolchildren with iodine deficiency. Int. J. Vitam. Nutr. Res. Suppl. 1994, 65: 199–205.
Azizi F., Khoshniat M., Bahrainian M., Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J. Clin. Endocrinol. Metab. 2000, 85: 3233–3238.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Azizi, F., Khamseh, M.E., Bahreynian, M. et al. Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 25, 586–589 (2002). https://doi.org/10.1007/BF03345080
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345080